Market Closed -
Swiss Exchange
16:30:44 03/05/2024 BST
|
5-day change
|
1st Jan Change
|
83.3
CHF
|
+0.97%
|
|
+1.59%
|
+3.09%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,992
|
1,416
|
1,817
|
1,873
|
-
|
-
|
Enterprise Value (EV)
1 |
1,876
|
1,322
|
1,817
|
1,751
|
1,741
|
1,873
|
P/E ratio
|
105
x
|
75
x
|
69.1
x
|
46.1
x
|
34.4
x
|
-
|
Yield
|
0.27%
|
0.4%
|
-
|
0.72%
|
0.98%
|
-
|
Capitalization / Revenue
|
8.5
x
|
5.11
x
|
5.68
x
|
4.8
x
|
4.06
x
|
3.77
x
|
EV / Revenue
|
8.01
x
|
4.77
x
|
5.68
x
|
4.49
x
|
3.77
x
|
3.77
x
|
EV / EBITDA
|
61.1
x
|
32.9
x
|
36.2
x
|
28.3
x
|
21.4
x
|
-
|
EV / FCF
|
-65.3
x
|
37.4
x
|
-
|
171
x
|
80.3
x
|
31.2
x
|
FCF Yield
|
-1.53%
|
2.67%
|
-
|
0.59%
|
1.24%
|
3.2%
|
Price to Book
|
12.5
x
|
9
x
|
-
|
8.85
x
|
7.02
x
|
-
|
Nbr of stocks (in thousands)
|
22,484
|
22,484
|
22,484
|
22,484
|
-
|
-
|
Reference price
2 |
88.60
|
63.00
|
80.80
|
83.30
|
83.30
|
83.30
|
Announcement Date
|
05/04/22
|
28/03/23
|
26/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
234.3
|
277
|
320
|
389.8
|
461.7
|
497.3
|
EBITDA
1 |
30.68
|
40.15
|
50.14
|
61.8
|
81.37
|
-
|
EBIT
1 |
23.06
|
29.46
|
37.75
|
48.4
|
65.47
|
76.1
|
Operating Margin
|
9.84%
|
10.64%
|
11.8%
|
12.42%
|
14.18%
|
15.3%
|
Earnings before Tax (EBT)
1 |
24.73
|
25.24
|
32.79
|
50.3
|
68.77
|
-
|
Net income
1 |
21.4
|
18.99
|
26.31
|
40.6
|
54.47
|
-
|
Net margin
|
9.13%
|
6.86%
|
8.22%
|
10.41%
|
11.8%
|
-
|
EPS
2 |
0.8400
|
0.8400
|
1.170
|
1.805
|
2.420
|
-
|
Free Cash Flow
1 |
-28.7
|
35.35
|
-
|
10.27
|
21.67
|
60
|
FCF margin
|
-12.25%
|
12.77%
|
-
|
2.63%
|
4.69%
|
12.07%
|
FCF Conversion (EBITDA)
|
-
|
88.05%
|
-
|
16.61%
|
26.63%
|
-
|
FCF Conversion (Net income)
|
-
|
186.21%
|
-
|
25.29%
|
39.78%
|
-
|
Dividend per Share
2 |
0.2400
|
0.2500
|
-
|
0.6000
|
0.8200
|
-
|
Announcement Date
|
05/04/22
|
28/03/23
|
26/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 S1
|
2023 S1
|
---|
Net sales
1 |
120.9
|
139.7
|
EBITDA
1 |
10.68
|
18.6
|
EBIT
1 |
-
|
12.4
|
Operating Margin
|
-
|
8.87%
|
Earnings before Tax (EBT)
1 |
-
|
10.24
|
Net income
1 |
-
|
7.804
|
Net margin
|
-
|
5.58%
|
EPS
|
-
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
23/08/22
|
22/08/23
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
116
|
94.1
|
-
|
122
|
132
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-28.7
|
35.4
|
-
|
10.3
|
21.7
|
60
|
ROE (net income / shareholders' equity)
|
10.5%
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
3.59%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
596.1
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
7.100
|
7.000
|
-
|
9.410
|
11.90
|
-
|
Cash Flow per Share
2 |
0.8200
|
2.730
|
-
|
2.050
|
2.950
|
-
|
Capex
1 |
39
|
26.1
|
-
|
34.3
|
50.7
|
30.7
|
Capex / Sales
|
16.66%
|
9.43%
|
-
|
8.8%
|
10.97%
|
6.17%
|
Announcement Date
|
05/04/22
|
28/03/23
|
26/03/24
|
-
|
-
|
-
|
Last Close Price
83.3
CHF Average target price
91.33
CHF Spread / Average Target +9.64% Consensus |
1st Jan change
|
Capi.
|
---|
| +3.09% | 2.07B | | +73.37% | 12.39B | | -17.09% | 8.08B | | +16.88% | 7.25B | | +3.57% | 5.86B | | +11.77% | 5.35B | | +29.65% | 4.63B | | -17.74% | 4.19B | | -35.26% | 2.44B | | +4.85% | 1.88B |
Medical Equipment
|